Key Figures (E million)
First quarter ended 31.3
	2020	2019
Order Intake	629.4	482.8
Of Which:
Bioprocess Solutions	506.2	360.7
Lab Products & Services	123.3	122.1
Sales Revenue	509.9	435.7
Of Which:
Bioprocess Solutions	394.3	320.7
Lab Products & Services	115.6	115.0
Underlying EBITDA	137.9	114.0
Of Which:
Bioprocess Solutions	119.9	90.9
Lab Products & Services	18.0	23.2
Net Profit	57.1	48.6

Source: Sartorius Q1 2020 results.